Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Marein ameliorates the progression of osteoarthritis: An in vitro and in vivo studies. | Int Immunopharmacol | 2025 | 39608176 | PubTator, text mining | PubMed |
| Inhibition of CRLF1 expression by miR-8485 alleviates IL-1β-induced chondrocyte inflammation, apoptosis, and extracellular matrix degradation. | Int Immunopharmacol | 2025 | 39580860 | PubTator, text mining | PubMed |
| Role of long non‑coding RNA leucine‑rich repeat containing 75 A‑antisense RNA1 in the invasion and progression of renal cell carcinoma. | Oncol Rep | 2025 | 39575481 | PubTator, text mining | PubMed |
| Effects of iron overload in human joint tissue explant cultures and animal models. | J Mol Med (Berl) | 2025 | 39531048 | PubTator, text mining | PubMed |
| The Impact of Selenium Deficiency and T-2 Toxin on Zip6 Expression in Kashin-Beck Disease. | Biol Trace Elem Res | 2025 | 39455492 | PubTator, text mining | PubMed |
Degradomics defines proteolysis information flow from human knee osteoarthritis cartilage to matched synovial fluid and the contributions of secreted proteases ADAMTS5, MMP13 and CMA1 to articular cartilage breakdown. | Osteoarthritis Cartilage | 2025 | 39293776 | PubTator, text mining | PubMed |
| A comprehensive analysis of vasculogenic mimicry related genes to predict the survival rate of HCC and its influence on the tumor microenvironment. | Front Genet | 2024 | 39748947 | PubTator, text mining | PubMed |
| Translational pharmacokinetic and pharmacodynamic modelling of the anti-ADAMTS-5 NANOBODY® (M6495) using the neo-epitope ARGS as a biomarker. | J Pharmacokinet Pharmacodyn | 2024 | 39704923 | PubTator, text mining | PubMed |
| [Mechanism of kaempferol on intervertebral disc degeneration based on p38 MAPK signaling pathway]. | Zhongguo Zhong Yao Za Zhi | 2024 | 39701783 | PubTator, text mining | PubMed |
| Dehydroepiandrosterone inhibits ADAMTS expression via an ERK-dependent mechanism in chondrocytes. | PLoS One | 2024 | 39576807 | PubTator, text mining | PubMed |
| Exosomes to exosome-functionalized scaffolds: a novel approach to stimulate bone regeneration. | Stem Cell Res Ther | 2024 | 39521993 | PubTator, text mining | PubMed |
| Exploring Intra-Articular Administration of Monoclonal Antibodies as a Novel Approach to Osteoarthritis Treatment: A Systematic Review. | Biomedicines | 2024 | 39457530 | PubTator, text mining | PubMed |
| Differential effects of alendronate on chondrocytes, cartilage matrix and subchondral bone structure in surgically induced osteoarthritis in mice. | Sci Rep | 2024 | 39443554 | PubTator, text mining | PubMed |
| Amentoflavone maintaining extracellular matrix homeostasis and inhibiting subchondral bone loss in osteoarthritis by inhibiting ERK, JNK and NF-κB signaling pathways. | J Orthop Surg Res | 2024 | 39407273 | PubTator, text mining | PubMed |
| Wedelolactone alleviates inflammation and cartilage degeneration by suppressing the NF-κB signaling pathway in osteoarthritis. | Int Immunopharmacol | 2024 | 39388895 | PubTator, text mining | PubMed |
| Protein Kinase C and Matrix Metalloproteinases Expression Using Phorbol Myristate Acetate in Degenerative Intervertebral Disc Cells. | Clin Orthop Surg | 2024 | 39364116 | PubTator, text mining | PubMed |
Targeting PAR2-mediated inflammation in osteoarthritis: a comprehensive in vitro evaluation of oleocanthal's potential as a functional food intervention for chondrocyte protection and anti-inflammatory effects. | BMC Musculoskelet Disord | 2024 | 39354427 | PubTator, text mining | PubMed |
| Predicting gene signature in breast cancer patients with multiple machine learning models. | Discov Oncol | 2024 | 39352418 | PubTator, text mining | PubMed |
| Disuse atrophy of articular cartilage can be restored by mechanical reloading in mice. | Mol Biol Rep | 2024 | 39331223 | PubTator, text mining | PubMed |
| Intervertebral disc degenerative disease in South Africa: a case-control analysis of selected gene variants. | Mol Biol Rep | 2024 | 39287911 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=8